OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
15.05
-0.15 (-0.99%)
Jun 12, 2025, 4:00 PM - Market closed
OptimizeRx Market Cap
OptimizeRx has a market cap or net worth of $278.35 million as of June 13, 2025. Its market cap has increased by 17.75% in one year.
Market Cap
278.35M
Enterprise Value
294.58M
1-Year Change
17.75%
Ranking
Category
Stock Price
$15.05
Market Cap Chart
Since June 22, 2018, OptimizeRx's market cap has increased from $34.20M to $278.35M, an increase of 713.89%. That is a compound annual growth rate of 35.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 11, 2025 | 281.10M | 214.08% |
| Dec 31, 2024 | 89.50M | -65.55% |
| Dec 29, 2023 | 259.80M | -9.85% |
| Dec 30, 2022 | 288.20M | -73.89% |
| Dec 31, 2021 | 1.10B | 134.43% |
| Dec 31, 2020 | 470.80M | 223.35% |
| Dec 31, 2019 | 145.60M | 10.47% |
| Dec 31, 2018 | 131.80M | 285.38% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 726.81B |
| Johnson & Johnson | 376.19B |
| Novo Nordisk | 353.21B |
| AbbVie | 338.65B |
| UnitedHealth Group | 287.33B |
| Abbott Laboratories | 236.41B |
| Novartis AG | 231.84B |
| AstraZeneca | 229.07B |